CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITIS
- 7 April 1973
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 301 (7806), 735-737
- https://doi.org/10.1016/s0140-6736(73)92125-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprineGut, 1972
- Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein bindingGut, 1972
- Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsyDigestive Diseases and Sciences, 1971
- Chronic Active and Lupoid Hepatitis Caused by a Laxative, OxyphenisatinThe New England Journal of Medicine, 1971
- PREDNISONE SIDE-EFFECTS AND SERUM-PROTEIN LEVELSThe Lancet, 1971
- SERUM IMMUNOSUPPRESSIVE ACTIVITY DUE TO AZATHIOPRINE AND ITS RELATION TO HEPATIC FUNCTION AFTER LIVER TRANSPLANTATIONThe Lancet, 1970
- Active chronic hepatitisAmerican Journal Of Medicine, 1970
- A CLASSIFICATION OF CHRONIC HEPATITISThe Lancet, 1968
- Conversion of cortisone to cortisol and prednisone to prednisolone.BMJ, 1967
- Suppression of plasma cell hepatitis with 6-mercaptopurineAmerican Journal Of Medicine, 1964